
    
      All patients who meet the inclusion criteria and giving written informed consent will be
      randomized.

      Every patient will be treated with a single injection of Filtered Autologous Adipose Tissue
      in one knee and single injection of Placebo in the other, based on the randomization.

      After the treatment patients will be followed up to 24 months.
    
  